Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Lupin Pharmaceuticals Inc.: Metformin Hydrochloride Extended-release Tablets USP Recalled for Impurity

Agency Publication Date: June 20, 2020
Share:
Sign in to monitor this recall

Summary

Lupin Pharmaceuticals Inc. has voluntarily recalled 6,540 bottles of Metformin Hydrochloride Extended-release Tablets USP (500 mg, 60-count bottles) after FDA testing revealed the presence of an impurity called N-Nitrosodimethylamine (NDMA). NDMA is classified as a probable human carcinogen, meaning long-term exposure to levels above acceptable limits may increase the risk of cancer. This recall affects generic Metformin (an Rx medication) with NDC number 68180-336-07 and expiration date 12/2020. Consumers should continue taking their medication but contact their doctor or pharmacist immediately for a replacement or alternative treatment to avoid health risks from stopping their diabetes medication abruptly.

Risk

The tablets contain N-Nitrosodimethylamine (NDMA) at levels that exceed the acceptable daily intake limit. NDMA is a known environmental contaminant and is classified as a probable human carcinogen based on results from laboratory tests.

What You Should Do

  1. Check your prescription bottle for 'Metformin Hydrochloride Extended-release Tablets USP, 500 mg' with NDC 68180-336-07 and Batch/Lot number G901203 with an expiration date of 12/2020.
  2. If you identify your bottle as part of this recall, do NOT stop taking your medication until you have spoken with your healthcare provider or pharmacist, as stopping diabetes medication suddenly can pose serious health risks.
  3. Contact your healthcare provider or pharmacist to obtain a replacement prescription or an alternative treatment for your condition.
  4. Return any remaining tablets from the affected lot to your pharmacy for a refund and further instructions.
  5. Contact Lupin Pharmaceuticals Inc. for more information or to report any issues at the manufacturer's contact details found on their website or through the pharmacy where the product was purchased.
  6. For additional questions or to report a complaint, call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund
How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.

Affected Products

Product: Metformin Hydrochloride Extended-release Tablets USP (500 mg, 60 count bottle)
Model:
NDC 68180-336-07
Recall #: D-1334-2020
Lot Numbers:
G901203 (Exp 12/2020)
Date Ranges: 12/2020

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 85840
Status: Resolved
Manufacturer: Lupin Pharmaceuticals Inc.
Sold By: Pharmacies
Manufactured In: India, United States
Units Affected: 6,540 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.